From: Prophylactic antibiotic regimens in tumor surgery (PARITY) survey
No. (%) | |||
---|---|---|---|
Any reduction at all | 15 | (21.7%) | |
Amount an alternative antibiotic drug and regimen needs to reduce infection rate before the improvement is considered "clinically important" | 5% | 10 | (14.5%) |
10% | 15 | (21.7%) | |
15% | 4 | (5.8%) | |
20% | 12 | (17.4%) | |
25% | 8 | (11.6%) | |
30% | 1 | (1.4%) | |
35% | 0 | (0.0%) | |
40% | 0 | (0.0%) | |
50% | 2 | (2.9%) | |
>50% | 2 | (2.9%) | |
I would participate in a multi-centre randomized controlled study assessing different antibiotic regimens in long-bone reconstruction for tumor surgery. | Yes | 61 | (87.1%) |
No | 9 | (12.9%) |